TrialDiabetes, obesity & metabolism2023

Effect of the glucagon-like peptide-1 receptor agonist liraglutide, compared to caloric restriction, on appetite, dietary intake, body fat distribution and cardiometabolic biomarkers: A randomized trial in adults with obesity and prediabetes.

Heidi J Silver et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.